Are you working with a business ? have business connections that would be interested in this funding? This call is now live.
UK businesses can apply for a share of up to £1 million for early-stage design projects working on identifying opportunities and generating ideas.
Innovate UK is to invest up to £1 million in early-stage design projects to help businesses identify high-value innovation opportunities and generate ideas. These should be for new products, services or business models that align with customer demand.
Proposals should use design-led methods from first principles to understand customer motivations and behaviour, inspire new ideas, support decision-making and inform strategy.
Projects are likley to to range in size from total costs of £20,000 to £100,000. Projects should last between 3 and 9 months.
A single UK business must lead the project:
- applications must be business led. Only individual UK based businesses are eligible to apply
- up to a maximum of 70% of the total eligible project costs can be allocated for the sub-contracting of design services to one or more other UK registered businesses
For more information click on the relevant links below:











Dr. Paul Whittington attends Technology and the SEND Reforms Roundtable in the House of Commons
Dr. Paul Whittington joins Bett 2026 DfE Assistive Technology Roundtable
BU Prof Jonathan Parker promoting social work in Malaysia
New interdisciplinary paper accepted for publication
Three NIHR Internships awarded at BU
Research highlighted at the UN in New York
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease